WallStSmart
SXTC

China SXT Pharmaceuticals Inc

NASDAQ: SXTC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$2.06
+0.49% today

Updated 2026-04-30

Market cap
$2.00M
P/E ratio
P/S ratio
1.30x
EPS (TTM)
$-57.15
Dividend yield
52W range
$1 – $368
Volume
0.1M

China SXT Pharmaceuticals Inc (SXTC) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$3.72M$4.88M$7.02M$7.01M$5.16M$4.78M$2.60M$1.97M$1.93M$1.74M
Revenue growth (YoY)+31.3%+43.8%-0.1%-26.4%-7.5%-45.5%-24.2%-2.2%-9.7%
Cost of revenue$2.92M$2.57M$3.62M$2.40M$2.46M$1.94M$1.35M$1.55M$1.37M$1.37M
Gross profit$793988.00$2.31M$3.40M$4.61M$2.70M$2.84M$1.25M$426271.00$553971.00$367427.00
Gross margin21.4%47.4%48.5%65.8%52.4%59.4%48.1%21.6%28.7%21.1%
R&D$184194.00$191393.00
SG&A$433819.00$565455.00$1.26M$1.24M$2.46M$3.45M$5.52M$5.65M$2.64M$2.76M
Operating income$209140.00$1.60M$1.63M$1.77M$-1.34M$-2.20M$-5.19M$-5.61M$-2.52M$-2.68M
Operating margin5.6%32.8%23.3%25.2%-26.0%-46.0%-199.4%-284.4%-130.4%-154.0%
EBITDA$298105.00$1.70M$1.76M$1.98M$-1.01M$-1.85M$-5.05M$-5.21M$-2.35M$-2.57M
EBITDA margin8.0%34.9%25.1%28.2%-19.6%-38.8%-194.1%-264.1%-121.9%-147.8%
EBIT$209141.00$1.60M$1.63M$1.80M$-1.34M$-2.20M$-5.37M$-5.46M$-2.55M$-2.66M
Interest expense$51059.00$40390.00$779.00$5174.00$3.35M$1.62M$36695.00$476776.00$544279.00$648221.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$141544.00$1.19M$1.19M$1.54M$-10.29M$-2.75M$-5.74M$-5.93M$-3.10M$-3.30M
Net income growth (YoY)+737.3%+0.2%+29.6%-768.4%+73.3%-108.7%-3.5%+47.8%-6.6%
Profit margin3.8%24.3%16.9%22.0%-199.3%-57.5%-220.4%-301.0%-160.7%-189.8%